- Several major pharmaceutical companies are key players in the drug delivery market.
- AbbVie, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca participated in drug delivery innovation discussions and partnerships.
Major pharmaceutical companies licensed drug delivery technologies like Enhanze and Hypercon for various applications.
3 reports, 2 independent
Updated 00:00
Still developing
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Major pharmaceutical companies licensed drug delivery technologies like Enhanze and Hypercon for various applications.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Numerous pharma companies secured licenses for ENHANZE technology, while CMS rules impact royalty revenue.1 source
BMS, Roche, Pfizer, and AbbVie licensed Enhanze technology for subcutaneous formulations.1 source
Keep exploring
The entities involved
-
Bristol-Myers Squibb
American pharmaceutical company
-
Hoffmann-La Roche
Swiss healthcare company
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
Related events
- Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.
- BioNTech announced new partnerships with Genmab, Pfizer, Bristol-Myers Squibb, and Genentech.
- AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.